Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.

Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.

Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.

Diffusion disk susceptibility testing with cefotaxime.

Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests.

Disk agar diffusion susceptibility testing of yeasts.

Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae.

In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.

Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.

Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.

Reevaluation of the disk diffusion method for sulfonamide susceptibility testing of Neisseria meningitidis.

Evaluation of the teicoplanin broth microdilution and disk diffusion susceptibility tests and recommended interpretive criteria.

In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.

Correlation of netilmicin disk diffusion susceptibility and agar dilution susceptibility.

Comparison of direct and standardized disk diffusion susceptibility testing of urine cultures.

Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia.

Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.

Direct disk diffusion susceptibility testing from respiratory tract specimens: focus on Pseudomonas aeruginosa.

Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.

In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.

Interpretive criteria of antimicrobial disk susceptibility tests with flomoxef.

An automated antimicrobial susceptibility system versus the Kirby-Bauer disk diffusion test for antimicrobial susceptibility.

Evaluation of an Automated System for Reading and Interpreting Disk Diffusion Antimicrobial Susceptibility Testing of Fastidious Bacteria.

Standardization of Operator-Dependent Variables Affecting Precision and Accuracy of the Disk Diffusion Method for Antibiotic Susceptibility Testing.

Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion.

Suggest Documents

Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.

Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.

Diffusion disk susceptibility testing with cefotaxime.

Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests.

Disk agar diffusion susceptibility testing of yeasts.

Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae.

In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.

Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.

Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.

Reevaluation of the disk diffusion method for sulfonamide susceptibility testing of Neisseria meningitidis.

Evaluation of the teicoplanin broth microdilution and disk diffusion susceptibility tests and recommended interpretive criteria.

In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.

Correlation of netilmicin disk diffusion susceptibility and agar dilution susceptibility.

Comparison of direct and standardized disk diffusion susceptibility testing of urine cultures.

Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia.

Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.

Direct disk diffusion susceptibility testing from respiratory tract specimens: focus on Pseudomonas aeruginosa.

Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.

In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.

Interpretive criteria of antimicrobial disk susceptibility tests with flomoxef.

An automated antimicrobial susceptibility system versus the Kirby-Bauer disk diffusion test for antimicrobial susceptibility.

Evaluation of an Automated System for Reading and Interpreting Disk Diffusion Antimicrobial Susceptibility Testing of Fastidious Bacteria.

Standardization of Operator-Dependent Variables Affecting Precision and Accuracy of the Disk Diffusion Method for Antibiotic Susceptibility Testing.

Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion.

Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.

Recommend Documents

Follow Us